Red blood cell derived extracellular vesicles during the process of autologous blood doping.
Autor: | Voss SC; Anti-Doping Lab Qatar, Doha, Qatar., Yassin M; Hamad Medical Corporation, Doha, Qatar., Grivel JC; Sidra Medicine, Deep Phenotyping Core - Research Department, Doha, Qatar., Al Hmissi S; Hamad Medical Corporation, Doha, Qatar., Allahverdi N; Hamad Medical Corporation, Doha, Qatar., Nashwan A; Hamad Medical Corporation, Doha, Qatar., Merenkov Z; Hamad Medical Corporation, Doha, Qatar., Abdulla M; Hamad Medical Corporation, Doha, Qatar., Al Malki A; Hamad Medical Corporation, Doha, Qatar., Raynaud C; Sidra Medicine, Deep Phenotyping Core - Research Department, Doha, Qatar., Elsaftawy W; Anti-Doping Lab Qatar, Doha, Qatar., Al Kaabi A; Anti-Doping Lab Qatar, Doha, Qatar., Donati F; Anti-Doping Lab FMSI, Rome, Italy., Botre F; Anti-Doping Lab FMSI, Rome, Italy., Mohamed Ali V; Anti-Doping Lab Qatar, Doha, Qatar.; Centre for Metabolism and Inflammation, Division of Medicine, University College London, London, UK., Georgakopoulos C; Anti-Doping Lab Qatar, Doha, Qatar., Al Maadheed M; Anti-Doping Lab Qatar, Doha, Qatar.; Centre for Metabolism and Inflammation, Division of Medicine, University College London, London, UK. |
---|---|
Jazyk: | angličtina |
Zdroj: | Drug testing and analysis [Drug Test Anal] 2022 Nov; Vol. 14 (11-12), pp. 1984-1994. Date of Electronic Publication: 2021 Sep 10. |
DOI: | 10.1002/dta.3157 |
Abstrakt: | The purpose of this pilot study was to investigate the effects of the transfusion of one erythrocyte concentrate on the number of circulating red blood cell extracellular vesicles (RBC-EVs) and their clearance time. Six, healthy volunteers donated their blood and were transfused with their RBC concentrate after 35-36 days of storage. One K (© 2021 The Authors. Drug Testing and Analysis published by John Wiley & Sons Ltd.) |
Databáze: | MEDLINE |
Externí odkaz: |